Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers.

Zhu HJ, Patrick KS, Straughn AB, Reeves OT 3rd, Bernstein H, Shi J, Johnson HJ, Knight JM, Smith AT, Malcolm RJ, Markowitz JS.

J Clin Psychopharmacol. 2017 Aug;37(4):419-428. doi: 10.1097/JCP.0000000000000721.

2.

Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis.

Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM.

JAMA Oncol. 2017 Jul 1;3(7):961-968. doi: 10.1001/jamaoncol.2016.6914. Review.

3.

Development of a refill pattern method to measure polypharmacy in administrative claims databases.

Liu X, Kubilis P, Bussing R, Winterstein AG.

Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1407-1413. doi: 10.1002/pds.4082. Epub 2016 Aug 16.

PMID:
27528378
4.

Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.

Sayer GR, McGough JJ, Levitt J, Cowen J, Sturm A, Castelo E, McCracken JT.

J Child Adolesc Psychopharmacol. 2016 Dec;26(10):882-888. Epub 2016 Aug 2.

5.

Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate.

Patrick KS, Straughn AB, Reeves OT 3rd, Bernstein H, Malcolm R.

J Clin Psychopharmacol. 2015 Aug;35(4):464-7. doi: 10.1097/JCP.0000000000000348.

6.
7.

Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.

Sugrue D, Bogner R, Ehret MJ.

Am J Health Syst Pharm. 2014 Jul 15;71(14):1163-70. doi: 10.2146/ajhp130638. Review.

PMID:
24973373
8.

Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.

Stein MA, Waldman I, Newcorn J, Bishop J, Kittles R, Cook EH Jr.

J Child Adolesc Psychopharmacol. 2014 Jun;24(5):238-44. doi: 10.1089/cap.2013.0102. Epub 2014 May 9.

9.
10.

Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder.

Silva RR, Brams M, McCague K, Pestreich L, Muniz R.

Clin Neuropharmacol. 2013 Jul-Aug;36(4):117-21. doi: 10.1097/WNF.0b013e31829aa92c.

PMID:
23860345

Supplemental Content

Loading ...
Support Center